Pembrolizumab in children, adolescents, and young adults with low-risk classic Hodgkin lymphoma (cHL) and slow early response to front-line chemotherapy: Updated results from the phase 2 KEYNOTE-667 study Meeting Abstract
| Authors: | Roth, L. G.; Toledo, M. M.; Keller, F. G.; Hoppe, B.; Forlenza, C. J.; Castellino, S. M.; Catalan, M. A.; Krystal, J.; Lamble, A.; Luisi, F.; Morales, F. M.; Rao, A. V.; Cooper, S.; Llano, O. G.; Villegas, L. J.; Mauz-Koerholz, C.; Shen, J.; Pillai, P.; Yusuf, R.; Kelly, K. M. |
| Abstract Title: | Pembrolizumab in children, adolescents, and young adults with low-risk classic Hodgkin lymphoma (cHL) and slow early response to front-line chemotherapy: Updated results from the phase 2 KEYNOTE-667 study |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 462 |
| End Page: | 463 |
| Language: | English |
| ACCESSION: | WOS:001415654100012 |
| DOI: | 10.1182/blood-2024-199263 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
